# Robert W. Schrier

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/robert-w-schrier/

## Facts

| Field | Value |
| --- | --- |
| Citations | 55,804 |
| Field | Electrolyte and hormonal disorders |
| h-index | 114 |
| i10-index | 513 |
| OpenAlex ID | https://openalex.org/A5108449499 |
| Works | 767 |

## Researcher papers

Showing 12 of 14.

- [Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis](https://scholariq.org/papers/peripheral-arterial-vasodilation-hypothesis-a-proposal-for-the-initiation-of/)
- [Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia](https://scholariq.org/papers/tolvaptan-a-selective-oral-vasopressin-v-sub-2-sub-receptor-antagonist-for/)
- [Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations](https://scholariq.org/papers/diagnosis-evaluation-and-treatment-of-hyponatremia-expert-panel-recommendations/)
- [Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/autosomal-dominant-polycystic-kidney-disease-adpkd-executive-summary-from-a/)
- [Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/blood-pressure-in-early-autosomal-dominant-polycystic-kidney-disease/)
- [The Renin–Angiotensin–Aldosterone System and Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/the-renin-angiotensin-aldosterone-system-and-autosomal-dominant-polycystic/)
- [Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease](https://scholariq.org/papers/rapamycin-markedly-slows-disease-progression-in-a-rat-model-of-polycystic-kidney/)
- [Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials](https://scholariq.org/papers/change-in-albuminuria-as-a-surrogate-endpoint-for-progression-of-kidney-disease/)
- [Radioimmunoassay of Plasma Arginine Vasopressin in Hyponatremic Patients with Congestive Heart Failure](https://scholariq.org/papers/radioimmunoassay-of-plasma-arginine-vasopressin-in-hyponatremic-patients-with/)
- [Oral Tolvaptan Is Safe and Effective in Chronic Hyponatremia](https://scholariq.org/papers/oral-tolvaptan-is-safe-and-effective-in-chronic-hyponatremia/)
- [Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/angiotensin-blockade-in-late-autosomal-dominant-polycystic-kidney-disease/)
- [Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion](https://scholariq.org/papers/efficacy-and-safety-of-oral-tolvaptan-therapy-in-patients-with-the-syndrome-of/)

## Researcher topics

- [Electrolyte and hormonal disorders](https://scholariq.org/topics/electrolyte-and-hormonal-disorders/)
- [Ion Transport and Channel Regulation](https://scholariq.org/topics/ion-transport-and-channel-regulation/)
- [Genetic and Kidney Cyst Diseases](https://scholariq.org/topics/genetic-and-kidney-cyst-diseases/)
- [Renal function and acid-base balance](https://scholariq.org/topics/renal-function-and-acid-base-balance/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.